Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation

Aim:Ursolic acid (UA) is a pentacyclic triterpenoid found in most plant species, which has been shown anti-inflammatory and anti-oxidative activities. In this study, we examined the effects of UA on collagen-induced arthritis (CIA) in mice, and to identify the mechanisms underlying the effects.Methods:CIA was induced in mice. Two weeks later, the mice were treated with UA (150 mg/kg, ip, 3 times per week) for 4 weeks. The expression of cytokines and oxidative stress markers in joint tissues was measured with immunohistochemistry. The numbers of CD4+IL-17+, CD4+CD25+Foxp3+ and pSTAT3 cells in spleens were determined using confocal immunostaining or flowcytometric analyses. Serum antibody levels and B cell-associated marker mRNAs were analyzed with ELISAs and qRT-PCR, respectively. CD4+ T cells and CD19+ B cells were purified from mice spleens for in vitro studies.Results:UA treatment significantly reduced the incidence and severity of CIA-induced arthritis, accompanied by decreased expression of proinflammatory cytokines (TNF-α, IL-1β, IL-6, IL-21 and IL-17) and oxidative stress markers (nitrotyrosine and iNOS) in arthritic joints. In CIA mice, UA treatment significantly decreased the number of Th17 cells, while increased the number of Treg cells in the spleens, which was consistent with decreased expression of pSTAT3, along with IL-17 and RORγt in the splenocytes. In addition, UA treatment significantly reduced the serum CII-specific IgG levels in CIA mice. The inhibitory effects of UA on Th17 cells were confirmed in an in vitro model of Th17 differentiation. Furthermore, UA dose-dependently suppressed the expression of B cell-associated markers Bcl-6, Blimp1 and AID mRNAs in purified CD19+ B cells pretreated with IL-21 or LPS in vitro.Conclusion:UA treatment significantly ameliorates CIA in mice via suppression of Th17 and differentiation. By targeting pathogenic Th17 cells and autoantibody production, UA may be useful for the treatment of autoimmune arthritis and other Th17-related diseases.

[1]  Sung-Hwan Park,et al.  STA‐21, a Promising STAT‐3 Inhibitor That Reciprocally Regulates Th17 and Treg Cells, Inhibits Osteoclastogenesis in Mice and Humans and Alleviates Autoimmune Inflammation in an Experimental Model of Rheumatoid Arthritis , 2014, Arthritis & rheumatology.

[2]  Qinghua Liang,et al.  Ursolic acid inhibits T-cell activation through modulating nuclear factor-κ B signaling , 2011, Chinese Journal of Integrative Medicine.

[3]  Seo‐Yeon Yoon,et al.  The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models. , 2008, The Journal of pharmacy and pharmacology.

[4]  D. Littman,et al.  Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.

[5]  A. Bishayee,et al.  Ursolic acid in cancer prevention and treatment: molecular targets, pharmacokinetics and clinical studies. , 2013, Biochemical pharmacology.

[6]  I. Wicks,et al.  Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis. , 2008, Arthritis and rheumatism.

[7]  S. Crotty,et al.  Effectors and memories: Bcl-6 and Blimp-1 in T and B lymphocyte differentiation , 2010, Nature Immunology.

[8]  Chi-Mei Ku,et al.  Anti-inflammatory effects of 27 selected terpenoid compounds tested through modulating Th1/Th2 cytokine secretion profiles using murine primary splenocytes. , 2013, Food chemistry.

[9]  Wenlin Huang,et al.  Ursolic Acid Simultaneously Targets Multiple Signaling Pathways to Suppress Proliferation and Induce Apoptosis in Colon Cancer Cells , 2013, PloS one.

[10]  A. Koch.  The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.

[11]  F. Andris,et al.  The capacity of Th2 lymphocytes to deliver B‐cell help requires expression of the transcription factor STAT3 , 2013, European journal of immunology.

[12]  Seo‐Yeon Yoon,et al.  The anti‐arthritic effect of ursolic acid on zymosan‐induced acute inflammation and adjuvant‐induced chronic arthritis models , 2008, The Journal of pharmacy and pharmacology.

[13]  N. Satti,et al.  Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production. , 2006, Pharmacological research.

[14]  Dong-Mei Wu,et al.  Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. , 2007, Biochemical pharmacology.

[15]  Y. Ikeda,et al.  Ursolic acid: an anti- and pro-inflammatory triterpenoid. , 2008, Molecular nutrition & food research.

[16]  Seung-Hyung Kim,et al.  Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma. , 2013, European journal of pharmacology.

[17]  Wei Cheng,et al.  Ursolic acid improves high fat diet-induced cognitive impairments by blocking endoplasmic reticulum stress and IκB kinase β/nuclear factor-κB-mediated inflammatory pathways in mice , 2011, Brain, Behavior, and Immunity.

[18]  D. Hwang,et al.  Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. , 2008, Immunity.

[19]  Y. Hseu,et al.  Triterpenoid Contents and Anti-Inflammatory Properties of the Methanol Extracts of Ligustrum Species Leaves , 2010, Molecules.

[20]  L. Joosten,et al.  IL-17 Promotes Bone Erosion in Murine Collagen-Induced Arthritis Through Loss of the Receptor Activator of NF-κB Ligand/Osteoprotegerin Balance 1 , 2003, The Journal of Immunology.

[21]  J. Kremer,et al.  Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. , 1998, Arthritis and rheumatism.

[22]  Thomas Korn,et al.  Proinflammatory T helper type 17 cells are effective B-cell helpers , 2010, Proceedings of the National Academy of Sciences.

[23]  D. Cua,et al.  Th17 cell development: from the cradle to the grave , 2013, Immunological reviews.

[24]  R. Nurieva,et al.  Ursolic Acid Suppresses Interleukin-17 (IL-17) Production by Selectively Antagonizing the Function of RORγt Protein* , 2011, The Journal of Biological Chemistry.

[25]  Dong-Mei Wu,et al.  Ursolic acid attenuates lipopolysaccharide-induced cognitive deficits in mouse brain through suppressing p38/NF-κB mediated inflammatory pathways , 2011, Neurobiology of Learning and Memory.

[26]  V. Poli,et al.  Critical role for Stat3 in T-dependent terminal differentiation of IgG B cells. , 2006, Blood.

[27]  B. Aggarwal,et al.  Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells , 2007, Molecular Cancer Research.

[28]  B. Blom,et al.  IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells , 2012, Immunology and cell biology.

[29]  Yanli Hao,et al.  Ursolic acid promotes cancer cell death by inducing Atg5‐dependent autophagy , 2013, International journal of cancer.

[30]  Chul-woo Yang,et al.  Gene Associated With Retinoid‐Interferon‐Induced Mortality 19 Attenuates Murine Autoimmune Arthritis by Regulation of Th17 and Treg Cells , 2014, Arthritis & rheumatology.

[31]  Y. Sung,et al.  IL-23 Induces Receptor Activator of NF-κB Ligand Expression on CD4+ T Cells and Promotes Osteoclastogenesis in an Autoimmune Arthritis Model1 , 2008, The Journal of Immunology.

[32]  David Jou,et al.  Ursolic acid inhibits the growth of colon cancer-initiating cells by targeting STAT3. , 2013, Anticancer research.